UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001714
Receipt number R000002064
Scientific Title Effect of imidapril or amlodipine on the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus: a randomized controlled study
Date of disclosure of the study information 2009/02/17
Last modified on 2009/02/17 17:58:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of imidapril or amlodipine on the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus: a randomized controlled study

Acronym

Effect of imidapril on the progression of diabetic nephropathy with type 2 DM

Scientific Title

Effect of imidapril or amlodipine on the progression of diabetic nephropathy in Japanese with type 2 diabetes mellitus: a randomized controlled study

Scientific Title:Acronym

Effect of imidapril on the progression of diabetic nephropathy with type 2 DM

Region

Japan


Condition

Condition

type 2 diabetes mellitus with hypertension

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To clarify and confirm the effect of ACE-1 in Type 2 daibetes with hypertension

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

urinary albumin excretion of imidapril

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

imidapril

Interventions/Control_2

amlodipine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

outpatient
BP>130/85(no medication)
Cre<2.5 mg/dl

Key exclusion criteria

renal stenosis and high renin activity
modelate liver injury
blood control poor
pregnancy

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshinari takamura

Organization

Kanazawa University Graduate School of Medical Science

Division name

Department of Disease Control and Homeostasis

Zip code


Address

13-1 Takara-machi, Kanazawa, Ishikawa

TEL

076-265-2233

Email



Public contact

Name of contact person

1st name
Middle name
Last name Toshinari takamura

Organization

Kanazawa University Graduate School of Medical Science

Division name

Department of Disease Control and Homeostasis

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Kanazawa University Graduate School of Medical Science Department of Disease Control and Homeostasis

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University Graduate School of Medical Science Department of Disease Control and Homeostasis

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 02 Month 17 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2001 Year 08 Month 31 Day

Date of IRB


Anticipated trial start date

2001 Year 09 Month 01 Day

Last follow-up date

2002 Year 08 Month 01 Day

Date of closure to data entry

2006 Year 12 Month 01 Day

Date trial data considered complete

2007 Year 04 Month 01 Day

Date analysis concluded

2008 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 02 Month 17 Day

Last modified on

2009 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002064